The "rule of halves" does not apply in Peru: Awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants

Critical Pathways in Cardiology

Volumn 12, Issue 2, 2013, Pages 53-58

  Lerner, Alana G ^a,b   Bernabe Ortiz, Antonio ^a,c   Gilman, Robert H ^a,d,e   Smeeth, Liam ^a,f   Miranda, J Jaime ^a,c  

^a CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cardiovascular diseases epidemiology; Risk factors; Rural health; Urban health

Indexed keywords

ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE; DIABETES MELLITUS; DISEASE CONTROL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRATION; PERU; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; URBAN AREA;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERU; PREVALENCE; RURAL POPULATION; SEX FACTORS; TRANSIENTS AND MIGRANTS; URBAN POPULATION;

EID: 84880228553     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e318285ef60     Document Type: Article

References (55)

1. World Health Organization. Preventing Chronic Diseases: A Vital Investment. Geneva: World Health Organization; 2005.
2. Joshi R, Jan S, Wu Y, MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol. 2008;52:1817-1825.
3. Institute of Medicine. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, DC: The National Academy Press; 2010.
4. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network metaanalysis. JAMA. 2003;289:2534-2544.
5. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
6. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829-841.
7. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.
8. Turner RC, Holman RR. Lessons from UK prospective diabetes study. Diabetes Res Clin Pract. 1995;28(suppl):S151-S157.
9. Crews DC, Plantinga LC, Miller ER 3rd, et al.; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension. 2010;55:1102-1109.
10. Elliott WJ. The economic impact of hypertension. J Clin Hypertens (Greenwich). 2003;5(3 suppl 2):3-13.
11. Gaziano TA, Bitton A, Anand S, et al.; International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:1472-1477.
12. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31:596-615.
13. Dall TM, Zhang Y, Chen YJ, et al. The economic burden of diabetes. Health Aff (Millwood). 2010;29:297-303.
14. Wilber JA. The problem of undetected and untreated hypertension in the community. Bull N Y Acad Med. 1973;49:510-520.
15. Wilber JA, Barrow JG. Hypertension-a community problem. Am J Med. 1972;52:653-663.
16. Hart JT. Rule of halves: implications of increasing diagnosis and reducing dropout for future workload and prescribing costs in primary care. Br J Gen Pract. 1992;42:116-119.
17. Alwan A, Maclean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376:1861-1868.
18. Gao M, Ikeda K, Hattori H, et al. Cardiovascular risk factors emerging in Chinese populations undergoing urbanization. Hypertens Res. 1999;22:209-215.
19. Niakara A, Fournet F, Gary J, et al. Hypertension, urbanization, social and spatial disparities: a cross-sectional population-based survey in a West African urban environment (Ouagadougou, Burkina Faso). Trans R Soc Trop Med Hyg. 2007;101:1136-1142.
20. Miranda JJ, Gilman RH, García HH, et al. The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study. BMC Cardiovasc Disord. 2009;9:23.
21. Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011;97:787-796.
22. Pedersen D, Tremblay J, Errázuriz C, et al. The sequelae of political violence: assessing trauma, suffering and dislocation in the Peruvian highlands. Soc Sci Med. 2008;67:205-217.
23. Instituto Nacional de Estadística e Informática. Migraciones internas en el Perú (Internal migration in Peru). Lima, Perú: INEI. Available at: http://www1.inei.gob.pe/biblioineipub/bancopub/ Est/Lib0018/n00.htm. Accessed September 1, 2012.
24. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531-536.
25. Chobanian AV, Bakris GL, Black HR, et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
26. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
27. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5-S20.
28. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization; 1997.
29. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316: 1236-1238.
30. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med. 1997;16:2529-2542.
31. Silva H, Hernandez-Hernandez R, Vinueza R, et al.; CARMELA Study Investigators. Cardiovascular risk awareness, treatment, and control in urban Latin America. Am J Ther. 2010;17:159-166.
32. Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, et al. Prevalence and patterns of hypertension in Peruvian Andean Hispanics: the PREVENCION study. J Am Soc Hypertens. 2007;1:216-225.
33. Ordúñez P, Barceló A, Bernal JL, et al. Risk factors associated with uncontrolled hypertension: findings from the baseline CARMEN survey in Cienfuegos, Cuba. J Hypertens. 2008;26:663-671.
34. Jo I, Ahn Y, Lee J, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens. 2001;19:1523-1532.
35. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
36. Pastorius Benziger C, Bernabe-Ortiz A, Miranda JJ, et al. Sex differences in health care-seeking behavior for acute coronary syndrome in a low income country, Peru. Crit Pathw Cardiol. 2011;10:99-103.
37. Wu Y, Huxley R, Li L, et al.; China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679-2686.
38. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
39. Falaschetti E, Chaudhury M, Mindell J, et al. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension. 2009;53:480-486.
40. International Diabetes Federation. Diabetes Atlas. 2nd ed. Brussels: International Diabetes Federation; 2003.
41. Aschner P. Diabetes trends in Latin America. Diabetes Metab Res Rev. 2002;18(suppl 3):S27-S31.
42. Hu D, Fu P, Xie J, et al.; MS for the InterASIA Collaborative Group. Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract. 2008;81:250-257.
43. Zhang Y, Dall TM, Mann SE, et al. The economic costs of undiagnosed diabetes. Popul Health Manag. 2009;12:95-101.
44. Scheltens T, Bots ML, Numans ME, et al. Awareness, treatment and control of hypertension: the 'rule of halves' in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21:99-106.
45. Weinehall L, Ohgren B, Persson M, et al. High remaining risk in poorly treated hypertension: the 'rule of halves' still exists. J Hypertens. 2002;20:2081-2088.
46. Chen R, Tunstall-Pedoe H, Morrison C, et al. Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited. J Hum Hypertens. 2003;17:751-759.
47. Deepa R, Shanthirani CS, Pradeepa R, et al. Is the 'rule of halves' in hypertension still valid?-Evidence from the Chennai Urban Population Study. J Assoc Physicians India. 2003;51:153-157.
48. Cruickshank JK, Mbanya JC, Wilks R, et al. Hypertension in four Africanorigin populations: current 'Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens. 2001;19:41-46.
49. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum; 2011.
50. Leon DA. Cities, urbanization and health. Int J Epidemiol. 2008;37:4-8.
51. Patel RB, Burke TF. Urbanization-an emerging humanitarian disaster. N Engl J Med. 2009;361:741-743.
52. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
53. van Ginkel H. Urban future. Nature. 2008;456:32-33.
54. United Nations Population Fund. The State of World Population 2007: Unleashing the Potential of Urban Growth. New York: UNFPA; 2007.
55. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.